Global Pyrazinamide Market, by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, by Patient Type (Adult and Pediatric), and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), is estimated to be valued at US$ 143.9 million as of 2020 and is expected to propel a CAGR of 4.6% over the forecast period (2020-2027), as highlighted in a new report published by Coherent Market Insights.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/4317
Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 epidemic has led to challenges for various markets and industries globally. Considering the rise of COVID-19 infections, societies and the healthcare facilities have put more focus on the healthcare industry which is expected to impose a positive as well as negative effect across all of its sub-sectors. In other words, the healthcare institutions, the pharmaceutical companies, retail and pharmaceutical distribution have been impacted negatively by the COVID-19 outbreak. As per the reports from World Health Organization, the ongoing COVID-19 disease has infected around 112,209,815 individuals and has result in 2,490,776 deaths globally as of February 25, 2021. The ongoing COVID-19 pandemic is impacting the businesses in different ways by influencing the production rate and its demand, disturbances in supply chains, and its effect on financial markets. This negative impact on the supply chain is expected to hinder growth of several pharmaceutical markets and the global pyrazinamide market is no different.
Furthermore, the players operating in the pyrazinamide market across the globe are facing major issues such as severe economic crisis and broken supply chain. The medical and healthcare industry is negatively impacted by the pandemic with consideration of service provided by the healthcare facilities. Hence, growth of the global pyrazinamide market is expected to experience a slowdown unless the pandemic is controlled.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4317
As per the World Health Organization (WHO), the South-East Asian (SEA) region is comprises of 26% of world’s population and has a burden of 44% of TB cases. The same source has estimated that around 4.3 million people are suffering from TB with 632,000 patients died because of the same disease.
Key Takeaways of the Global Pyrazinamide Market:
Due to the increasing product launches and their approvals, the global pyrazinamide market is expected to propel a CAGR of 4.6% over the forecast period (2020-2027).
Owing to the high prevalence of TB disease among the adult patients, the adult segment is expected to attain a major revenue share in 2017.
Key players contributing in the global pyrazinamide market are Waterstone Technology, LGM Pharma, City Chemical, and EDQM, J & K SCIENTIFIC, Toronto Research Chemicals, Meryer (Shanghai) Chemical Technology, Energy Chemical, Beijing Ouhe Technology, Pure Chemistry Scientific, TCI, HBCChem, Alfa Chemistry, Acros Organics, and AlliChem.
Reasons to Purchase this Report
• Current and future of global Pyrazinamide market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Patient Type
- Market Snapshot, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Key Developments
- Impact Analysis
- Mergers & Acquisitions
- New Product Launch
- Technology Overview
- PEST Analysis
- Market Dynamics
- Global Pyrazinamide Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID 19 Impact Analysis
- New Developments
- Global Pyrazinamide Market, By Patient Type, 2016 – 2027, (US$ million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Pyrazinamide Market, By Distribution Channel, 2016 – 2027, (US$ million)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Million)
- Introduction
- Global Pyrazinamide Market, By Region, 2016– 2027, (US$ Million)
- Introduction
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, By Region, 2017 – 2027
- Regional Trends
- North America
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.S.
- Canada
- Europe
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- China
- Japan
- India
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Share Analysis, By Patient Type, 2020 and 2027 (%)
- Market Share Analysis, By Distribution Channel, 2020 and 2027 (%)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Million)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Pure Chemistry Scientific
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- LGM Pharma
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- City Chemical
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- TCI
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- HBCChem
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Alfa Chemistry
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Toronto Research Chemicals
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Acros Organics
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- AlliChem
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Waterstone Technology
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Pure Chemistry Scientific
- Company Profiles
- Section
- References
- Research Methodology
- About Us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837